JP2018145180A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018145180A5 JP2018145180A5 JP2018034369A JP2018034369A JP2018145180A5 JP 2018145180 A5 JP2018145180 A5 JP 2018145180A5 JP 2018034369 A JP2018034369 A JP 2018034369A JP 2018034369 A JP2018034369 A JP 2018034369A JP 2018145180 A5 JP2018145180 A5 JP 2018145180A5
- Authority
- JP
- Japan
- Prior art keywords
- onychomycosis
- agent
- medicament according
- therapeutic agent
- following formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 7
- 208000010195 Onychomycosis Diseases 0.000 claims 4
- 201000005882 tinea unguium Diseases 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 125000005841 biaryl group Chemical class 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 201000009862 superficial mycosis Diseases 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017038752 | 2017-03-01 | ||
| JP2017038752 | 2017-03-01 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019004690A Division JP2019073537A (ja) | 2017-03-01 | 2019-01-15 | ビアリール誘導体又はその塩からなる医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018145180A JP2018145180A (ja) | 2018-09-20 |
| JP2018145180A5 true JP2018145180A5 (enExample) | 2018-12-27 |
| JP6469272B2 JP6469272B2 (ja) | 2019-02-13 |
Family
ID=63589494
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018034369A Active JP6469272B2 (ja) | 2017-03-01 | 2018-02-28 | ビアリール誘導体又はその塩からなる医薬 |
| JP2019004690A Pending JP2019073537A (ja) | 2017-03-01 | 2019-01-15 | ビアリール誘導体又はその塩からなる医薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019004690A Pending JP2019073537A (ja) | 2017-03-01 | 2019-01-15 | ビアリール誘導体又はその塩からなる医薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP6469272B2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ775496A (en) * | 2018-11-30 | 2026-01-30 | Otsuka Pharma Co Ltd | Heterocyclic compounds for the treatment of epilepsy |
| US20240262803A1 (en) * | 2021-03-24 | 2024-08-08 | Chungdu Anticancer Bioscience Ltd | Compounds, compositions and methods of treating disorders |
| WO2023027162A1 (ja) * | 2021-08-27 | 2023-03-02 | 科研製薬株式会社 | ２－（４－エチルフェノキシ）－４'－メトキシ－３，３'－ビピリジンの結晶及びその製造方法 |
| WO2023146512A1 (en) * | 2022-01-25 | 2023-08-03 | Vivace Therapeutics, Inc. | Compounds and methods of use thereof |
| WO2023146511A1 (en) * | 2022-01-25 | 2023-08-03 | Vivace Therapeutics, Inc. | Compounds and methods of use thereof |
| CN115304544B (zh) * | 2022-08-01 | 2024-02-09 | 童航 | 一种5-溴-2-(甲基氨基)吡啶的合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9505651D0 (en) * | 1995-03-21 | 1995-05-10 | Agrevo Uk Ltd | AgrEvo UK Limited |
| US6096895A (en) * | 1995-05-17 | 2000-08-01 | E. I. Du Pont De Nemours And Company | Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases |
| DE10038019A1 (de) * | 2000-08-04 | 2002-02-14 | Bayer Ag | Substituierte Triazolopyrid(az)ine |
| AU2003274025A1 (en) * | 2002-10-17 | 2004-05-04 | Syngenta Participations Ag | Pyridine derivatives useful as herbicides |
| WO2004052280A2 (en) * | 2002-12-10 | 2004-06-24 | Imclone Systems Incorporated | Anti-angiogenic compounds and their use in cancer treatment |
| US20050113423A1 (en) * | 2003-03-12 | 2005-05-26 | Vangoor Frederick F. | Modulators of ATP-binding cassette transporters |
| EP1888529A2 (en) * | 2005-05-18 | 2008-02-20 | Wyeth | 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same |
| UY32582A (es) * | 2009-04-28 | 2010-11-30 | Amgen Inc | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero |
| KR101301533B1 (ko) * | 2010-02-09 | 2013-09-04 | 한미사이언스 주식회사 | 암세포 성장 억제 효과를 갖는 신규 피리미딘 유도체 |
| ES2527188T3 (es) * | 2011-09-26 | 2015-01-21 | Sanofi | Derivados de pirazolquinolinona, su preparación y su uso terapéutico |
| WO2016098793A1 (ja) * | 2014-12-17 | 2016-06-23 | 塩野義製薬株式会社 | 環状グアニジル基を有するチアゾール誘導体 |
-
2018
- 2018-02-28 JP JP2018034369A patent/JP6469272B2/ja active Active
-
2019
- 2019-01-15 JP JP2019004690A patent/JP2019073537A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019194236A5 (enExample) | ||
| JP2019048894A5 (enExample) | ||
| JP2024071370A5 (enExample) | ||
| JP2018521020A5 (enExample) | ||
| JP2016514159A5 (enExample) | ||
| CN115667238A (zh) | 一种五并五元环衍生物及其在医药上的应用 | |
| JP2015078230A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| JP2017506627A5 (enExample) | ||
| PE20151542A1 (es) | Compuestos de tetrahidropirrolotiazina | |
| JP2023126440A5 (enExample) | ||
| JP2017222697A5 (enExample) | ||
| JOP20190182B1 (ar) | أسيتاميد n-] 4-فلور-5-]] (4s,2s)-2-ميثيل-4-](5-ميثيل-1،2،4-اوكسادايزول-3-يل)ميثوكسي[-1-بيبيرديل[ميثيل[ ثيازول-2-يل[ كمثبط oga | |
| JP2011518833A5 (enExample) | ||
| JP2013532687A5 (enExample) | ||
| JP2017509667A5 (enExample) | ||
| JP2015513557A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| JP2014507446A5 (enExample) | ||
| JP2014530818A5 (enExample) | ||
| JP2016518337A5 (enExample) | ||
| JP2018531941A5 (enExample) | ||
| JP2013532130A5 (enExample) | ||
| JOP20210329A1 (ar) | مركبات بيرازول مزدوجة الاستبدال كمثبطات كيتو هيكسو كيناز | |
| JP2017517565A5 (enExample) |